Sprengers E D, van Hinsbergh V W, Jansen B G
Biochim Biophys Acta. 1986 Sep 4;883(2):233-41. doi: 10.1016/0304-4165(86)90313-2.
In human endothelial cell conditioned medium a fast-acting inhibitor of tissue-type plasminogen activator and urokinase has been detected. Moreover, an inactive inhibitor of these plasminogen activators is present, that can be activated by denaturing agents such as sodium dodecyl sulphate (SDS). The mutual relationship between these inhibitors was studied. The fast-acting plasminogen activator inhibitor from human endothelial cell conditioned medium was purified in a complex with tissue-type plasminogen activator by immune adsorption, using an immobilized anti-tissue-type plasminogen activator antibody. With the complex as an antigen, specific antibodies were raised against this inhibitor in rabbits. The antiserum immunoreacted with both the inactive and the fast-acting plasminogen activator inhibitor. Endothelial cell conditioned medium (containing the inactive plasminogen activator inhibitor) was treated with SDS and the inhibitory activity that emerged was purified. The SDS-generated product formed complexes with tissue-type plasminogen activator with the same molecular mass as those formed with the fast-acting inhibitor. Moreover, the inhibitory activity generated by SDS treatment showed the same kinetic behaviour with tissue-type plasminogen activator as did the fast-acting inhibitor. These data show that the fast-acting and the inactive plasminogen activator inhibitor are immunologically and functionally related to each other, and probably represent different molecular forms of the same protein.
在人内皮细胞条件培养基中,已检测到一种组织型纤溶酶原激活剂和尿激酶的快速作用抑制剂。此外,还存在这些纤溶酶原激活剂的一种无活性抑制剂,其可被变性剂如十二烷基硫酸钠(SDS)激活。研究了这些抑制剂之间的相互关系。通过使用固定化抗组织型纤溶酶原激活剂抗体进行免疫吸附,从人内皮细胞条件培养基中纯化出与组织型纤溶酶原激活剂形成复合物的快速作用纤溶酶原激活剂抑制剂。以该复合物为抗原,在兔体内产生针对该抑制剂的特异性抗体。该抗血清与无活性和快速作用的纤溶酶原激活剂抑制剂均发生免疫反应。用SDS处理内皮细胞条件培养基(含有无活性纤溶酶原激活剂抑制剂),并纯化产生的抑制活性。SDS产生的产物与组织型纤溶酶原激活剂形成的复合物,其分子量与快速作用抑制剂形成的复合物相同。此外,SDS处理产生的抑制活性与组织型纤溶酶原激活剂的动力学行为,与快速作用抑制剂相同。这些数据表明,快速作用和无活性的纤溶酶原激活剂抑制剂在免疫学和功能上相互关联,可能代表同一蛋白质的不同分子形式。